Publications by authors named "Alessandra Mecozzi"

Claim this Profile
E
Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura.
Salvatore Perrone, Mauro Passucci, Elettra Ortu La Barbera, Marcello Capriata, Antonietta Ferretti, Alessandra Mecozzi

J Clin Apher· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia.
Valentina Perrone, Elisa Giacomini, Margherita Andretta, Loredana Arenare, Maria Rosaria Cillo, Alessandra Mecozzi

Ther Clin Risk Manag· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study.
Simone Lanini, Paola Scognamiglio, Alessandra Mecozzi, Lorella Lombardozzi, Vincenzo Vullo

BMC Infect Dis· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region.
Francesco Trotta, Flavia Mayer, Alessandra Mecozzi, Laura Amato, Antonio Addis

BioDrugs· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy.
Francesco Trotta, Valeria Belleudi, Danilo Fusco, Laura Amato, Alessandra Mecozzi

BMJ Open· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis